Patent details

EP3842034 Title: ANTICANCER COMPOSITIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3842034
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP20209559.2
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
03/12/2015
Grant date:
12/02/2025
EP Publication Date:
30/06/2021
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
24/03/2025
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
12/02/2025
EP B1 Publication Date:
12/02/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
02/12/2035
Lapsed By Expiration Date:
Patent Validated Date:
04/04/2025
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
12/02/2025
 
 

 

Name:
Aragon Pharmaceuticals, Inc.
Address:
10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, United States of America (US)

Agent

Name:
ir. W.J.J.M. Kempes
From:
03/04/2025
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

Name:
VERRECK, Geert
Address:
2340 Beerse, Belgium (BE)

Priority

Priority Patent Number:
14196591
Priority Date:
05/12/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 9/00; A61K 9/14; A61K 9/20; A61P 13/08; A61K 31/4439; A61P 35/04; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
15/25
Publication date:
09/04/2025
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
07/25
Publication date:
12/02/2025
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202507
Publication date:
12/02/2025
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/12/2025
Annual Fee Number:
11
Annual Fee Amount:
500 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
03/04/2025 Outgoing Correspondence Letter no formal defects 1 PDF /8/7/0/5/8/0801085078/docs/ep20209559.2_1_650789l271.pdf
24/03/2025 Claims First filed claims 2 PDF /8/7/0/5/8/0801085078/docs/ep20209559.2_0_claims20250324194525641.pdf